10 likes | 131 Views
0. 0.5. 1. 2. Thr (min). eNOS. PKC d -pTyr 311. PKC d. †. eNOS-pSer 1179. eNOS-pThr 497. eNOS. A. B. *. 125. *. 100. 75. eNOS-p (%). †. 50. 25. 0. Thr. -. +. -. +. -. +. DMSO. Rott. LY. eNOS-pSer 1179. D. †. 150. 125. C.
E N D
0 0.5 1 2 Thr (min) eNOS PKCd-pTyr311 PKCd † eNOS-pSer1179 eNOS-pThr497 eNOS A B * 125 * 100 75 eNOS-p (%) † 50 25 0 Thr - + - + - + DMSO Rott LY eNOS-pSer1179 D † 150 125 C pSer1179 100 † 100 pThr497 eNOS-p (%) 75 75 50 eNOS-p (%) 50 25 0 25 - + + + Thr 0 - - co pre - + - + Rott PMA Basal A23 eNOS-pSer1179 eNOS On Line Figure I. A. HUVECs pretreated with 10 mol/L rottlerin (Rott), 10 mol/L LY294002 (LY), or control vehicle (0.1% DMSO) for 30 min were stimulated with 10 U/mL thrombin (Thr) for 1 min. B. BAECs were stimulated with thrombin for the indicated time periods. PKCd Tyr311 phosphorylation was evaluated by immunoblotting. C. BAECs pretreated with or without 10 mol/L rottlerin (Rott) for 30 min were stimulated with 10 mol/L A23187 for 1 min. D. BAECs co-treated (co) or pretreated (pre 5 min) with 1 mol/L PMA were stimulated with 10 U/mL thrombin for 1 min. These data shown are representative of 3 separate experiments giving similar results (mean + SEM. *p < 0.05 compared to basal. †p < 0.05 compared to stimulated control.).